About this FactMed analysis covering adverse side effect reports of AIRBORNE patients who developed RHINORRHOEA.

FactMed provides MD-approved analysis to help both patients, researchers, and physicians accurately assess the risk profile for more than 20,000 different pharmaceutical products. The below report offers compiled information from Food & Drug Administration and FactMed user submissions. Between January 2004 and October 2012, 1 individuals taking AIRBORNE reported RHINORRHOEA to the FDA. A total of 20 AIRBORNE drug adverse event reaction reports were made with the FDA during this time period. Often the FDA only receives reports of the most critical and severe cases; these numbers may therefore underrepresent the complication rate of the medication.

FDA Research Report

Introduction This page is designed to help you determine the relationship, if any, between AIRBORNE and RHINORRHOEA. In doing so, we compare AIRBORNE with other drugs that cause RHINORRHOEA, to help you evaluate whether or not AIRBORNE causes RHINORRHOEA. Likewise, this page shows the most highly-reported side effects of AIRBORNE, so you can see if RHINORRHOEA ranks among AIRBORNE's most well-known side effects.
Summary Statistics
Reports of AIRBORNE causing RHINORRHOEA: 1
Reports of any side effect of AIRBORNE : 20
Percentage of AIRBORNE patients where RHINORRHOEA is a reported side effect: 5.0000%

FDA reports of any drug causing RHINORRHOEA : 9244
Average percentage for all medicated patients where RHINORRHOEA is reported as a complication: 0.0579%

Physician opinion on AIRBORNE as adverse event culprit:

Overall opinion for all reports of this drug:
Most frequent diagnoses/indications for prescribing AIRBORNE:
MEDICAL DIET ( 3 patients )
DRUG USE FOR UNKNOWN INDICATION ( 3 patients )
PRODUCT USED FOR UNKNOWN INDICATION ( 1 patients )
NASOPHARYNGITIS ( 1 patients )
SUPPLEMENTATION THERAPY ( 1 patients )
( 0 patients )
Drugs with high FDA adverse event association with RHINORRHOEA:

ENBREL (1420 patients)
HUMIRA (1145 patients)
ASPIRIN (730 patients)
FOSAMAX (569 patients)
METHOTREXATE (480 patients)
XOLAIR (480 patients)
PREDNISONE (388 patients)
LIPITOR (387 patients)
FOLIC ACID (354 patients)
LISINOPRIL (325 patients)
NEXIUM (325 patients)
SANDOSTATIN LAR (324 patients)
SEROQUEL (320 patients)
SYNTHROID (309 patients)
ZOMETA (307 patients)
JANUVIA (302 patients)
FORTEO (297 patients)
VIOXX (292 patients)
ATENOLOL (273 patients)
LASIX (272 patients)
COUMADIN (270 patients)
ALBUTEROL (261 patients)
VITAMIN D (259 patients)
SYNAGIS (257 patients)
FLOMAX (242 patients)
AREDIA (239 patients)
ZOLOFT (235 patients)
CELEBREX (229 patients)
ADVAIR DISKUS 100/50 (224 patients)
NORVASC (221 patients)
SPIRIVA (220 patients)
CALCIUM (216 patients)
XANAX (212 patients)
BYETTA (212 patients)
FUROSEMIDE (208 patients)
PROTONIX (205 patients)
PRILOSEC (205 patients)
ACETAMINOPHEN (204 patients)
LEVOTHYROXINE SODIUM (200 patients)
OMEPRAZOLE (197 patients)
PREVACID (193 patients)
SIMVASTATIN (190 patients)
HYDROCHLOROTHIAZIDE (187 patients)
MULTI-VITAMINS (186 patients)
CRESTOR (182 patients)
TYSABRI (182 patients)
SOLIRIS (180 patients)
ZOCOR (180 patients)
SINGULAIR (177 patients)
REMICADE (174 patients)
LORAZEPAM (172 patients)
AMBIEN (172 patients)
OXYCONTIN (170 patients)
LEVAQUIN (170 patients)
DIOVAN (169 patients)
NEURONTIN (169 patients)
PLAVIX (168 patients)
ZYRTEC (163 patients)
PREDNISONE TAB (160 patients)
SYMBICORT (159 patients)
EXJADE (157 patients)
METFORMIN HCL (151 patients)
LEXAPRO (151 patients)
AVONEX (150 patients)
PAXIL (147 patients)
POTASSIUM CHLORIDE (146 patients)
TOPROL-XL (143 patients)
DIGOXIN (143 patients)
IBUPROFEN (140 patients)
ATIVAN (139 patients)
FLONASE (136 patients)
LANTUS (135 patients)
FISH OIL (135 patients)
COREG (132 patients)
WARFARIN SODIUM (132 patients)
ZANTAC (132 patients)
MULTI-VITAMIN (132 patients)
DEXAMETHASONE (131 patients)
CLONAZEPAM (129 patients)
CLARITIN (128 patients)
DECADRON (128 patients)
VICODIN (126 patients)
AMOXICILLIN (125 patients)
PROZAC (124 patients)
GLIPIZIDE (123 patients)
PREMARIN (122 patients)
LYRICA (122 patients)
ALLEGRA (118 patients)
ALPRAZOLAM (118 patients)
LORTAB (118 patients)
ASCORBIC ACID (116 patients)
PERCOCET (115 patients)
GLUCOPHAGE (112 patients)
RANITIDINE (111 patients)
BENADRYL (110 patients)
ALLOPURINOL (109 patients)
GABAPENTIN (106 patients)
ZETIA (105 patients)
OXYCODONE HCL (105 patients)
ACCUTANE (104 patients)
ZITHROMAX (104 patients)
ACTOS (101 patients)
REVLIMID (101 patients)
TRAMADOL HCL (101 patients)
NASONEX (100 patients)
CYMBALTA (99 patients)
KLONOPIN (97 patients)
KEFLEX (95 patients)
CHANTIX (95 patients)
VITAMIN B-12 (94 patients)
SPIRONOLACTONE (94 patients)
GLUCOSAMINE (93 patients)
METOPROLOL TARTRATE (90 patients)
RHINOCORT (90 patients)
TYLENOL (CAPLET) (88 patients)
ZOFRAN (87 patients)
CALCIUM CARBONATE (86 patients)
REGLAN (86 patients)
METRONIDAZOLE (85 patients)
ACTONEL (85 patients)
COZAAR (84 patients)
INSULIN (84 patients)
VITAMIN E (84 patients)
WELLBUTRIN (83 patients)
GLYBURIDE (82 patients)
AMLODIPINE (81 patients)
CLINDAMYCIN (80 patients)
FLUCONAZOLE (79 patients)
LAMICTAL (78 patients)
ELIDEL (77 patients)
PULMICORT (77 patients)
IRON (77 patients)
FLEXERIL (76 patients)
TYLENOL (76 patients)
HUMALOG (76 patients)
LANSOPRAZOLE (76 patients)
CLONIDINE (75 patients)
RAMIPRIL (75 patients)
TRAZODONE HCL (75 patients)
OMALIZUMAB (74 patients)
PROVIGIL (74 patients)
FLOVENT (74 patients)
EFFEXOR (73 patients)
ARIMIDEX (73 patients)
HYDROCODONE (72 patients)
DURAGESIC-100 (72 patients)
METFORMIN (71 patients)
MORPHINE SULFATE (71 patients)
AVELOX (70 patients)
MORPHINE (70 patients)
CYCLOPHOSPHAMIDE (70 patients)
LOVENOX (70 patients)
NEXAVAR (69 patients)
VENTOLIN (69 patients)
VIAGRA (69 patients)
PLAQUENIL (68 patients)
FLUTICASONE PROPIONATE (68 patients)
FLAGYL (68 patients)
ATROVENT (67 patients)
AUGMENTIN '125' (67 patients)
CIPROFLOXACIN (67 patients)
FEMARA (67 patients)
CELEXA (66 patients)
DILAUDID (66 patients)
NIASPAN (66 patients)
VALIUM (65 patients)
FERROUS SULFATE TAB (65 patients)
COLACE (65 patients)
BENICAR (64 patients)
ULTRAM (64 patients)
KEPPRA (64 patients)
PREDNISOLONE (63 patients)
SULFASALAZINE (62 patients)
LEVOXYL (61 patients)
HEPARIN (61 patients)
GLEEVEC (61 patients)
PEPCID (61 patients)
ZYPREXA (61 patients)
NYSTATIN (61 patients)
XELODA (60 patients)
TYLENOL-500 (60 patients)
HYDROCODONE BITARTRATE (60 patients)
METOPROLOL (60 patients)
LORATADINE (59 patients)
BETASERON (59 patients)
ACIPHEX (59 patients)
ACYCLOVIR (59 patients)
COMBIVENT (59 patients)
METHADONE HCL (59 patients)
MEDROL (58 patients)
NITROGLYCERIN (58 patients)
CIMZIA (58 patients)
EXTAVIA (58 patients)
ALTACE (57 patients)
ENALAPRIL MALEATE (57 patients)
GILENYA (57 patients)
AVANDIA (57 patients)
LOPRESSOR (57 patients)
SOMA (56 patients)
COMPAZINE (56 patients)
BACLOFEN (56 patients)
METOCLOPRAMIDE (55 patients)
CARBOPLATIN (55 patients)
AMARYL (55 patients)
LOVAZA (55 patients)
CEPHALEXIN (54 patients)
POTASSIUM (54 patients)
HEPARIN SODIUM INJECTION (54 patients)
FAMOTIDINE (54 patients)
ALDACTONE (54 patients)
Most common side effects for patients taking AIRBORNE:
ALOPECIA (4 patients)
CONFUSIONAL STATE (4 patients)
AGEUSIA (3 patients)
ARTHRALGIA (3 patients)
LIGAMENT OPERATION (3 patients)
INFLUENZA (3 patients)
DRUG EFFECT DECREASED (3 patients)
ACTIVITIES OF DAILY LIVING IMPAIRED (2 patients)
VISION BLURRED (2 patients)
RESTLESSNESS (2 patients)
NASOPHARYNGITIS (2 patients)
MULTIPLE MYELOMA (2 patients)
CEREBROVASCULAR ACCIDENT (2 patients)
COORDINATION ABNORMAL (2 patients)
DRUG INEFFECTIVE (2 patients)
HYPOAESTHESIA (2 patients)
EPISTAXIS (2 patients)
DYSGRAPHIA (2 patients)
DYSARTHRIA (2 patients)
DRY SKIN (1 patients)
DYSPHEMIA (1 patients)
ECZEMA WEEPING (1 patients)
DRY MOUTH (1 patients)
ERYTHEMA (1 patients)
FATIGUE (1 patients)
FEELING ABNORMAL (1 patients)
GENITAL PAIN (1 patients)
HEADACHE (1 patients)
HEARING IMPAIRED (1 patients)
HEART RATE DECREASED (1 patients)
HYPERKERATOSIS (1 patients)
DRY EYE (1 patients)
HYPOREFLEXIA (1 patients)
CONSTIPATION (1 patients)
INJECTION SITE ERYTHEMA (1 patients)
INJECTION SITE IRRITATION (1 patients)
INJECTION SITE SWELLING (1 patients)
INSOMNIA (1 patients)
INTERNATIONAL NORMALISED RATIO ABNORMAL (1 patients)
LEARNING DISORDER (1 patients)
CONDITION AGGRAVATED (1 patients)
LIP SWELLING (1 patients)
LOCALISED INFECTION (1 patients)
LUNG NEOPLASM MALIGNANT (1 patients)
MEMORY IMPAIRMENT (1 patients)
APHASIA (1 patients)
ANXIETY (1 patients)
NAUSEA (1 patients)
NEOPLASM MALIGNANT (1 patients)
PRURITUS (1 patients)
PYREXIA (1 patients)
RASH (1 patients)
AMNESIA (1 patients)
RHINORRHOEA (1 patients)
SOMNOLENCE (1 patients)
SYNCOPE (1 patients)
URTICARIA (1 patients)
ACUTE SINUSITIS (1 patients)
WEIGHT INCREASED (1 patients)
WITHDRAWAL SYNDROME (1 patients)

In addition to reviewing our up-to-date FDA research, users may interact with the FactMed community - currently one million members and growing! FactMed online research and discussions are read by patients, scientists, physicians, and other interested health care parties. Post follow up Questions to learn from our diverse readership. Likewise, patients who have experienced unwanted effects are encouraged to share their Concerns to help educate and inform our members.


Recent FactMed Activity for AIRBORNE


Issue Description / Topic Timestamp
CONCERN
DRY MOUTH
Took last night have severe dry mouth 2015-11-18 06:01:39
QUESTION
INSOMNIA
I take Amitryptyline and Trazodone. When I use Airborne I cannot get to sleep. 2017-10-07 15:22:45

My Patient Resources

Get your questions answered! Over one million patients, researchers, and health care providers have visited FactMed. If you have a question about RHINORRHOEA and AIRBORNE, post it here. You may receive a response from a fellow patient - or a leading expert in the field.
Your Question:

Share your experience: Over one million patients, researchers, and health care providers have visited FactMed. If you have a noteworthy experience as a patient taking AIRBORNE, post it here. Your story could help a fellow patient - or provide insight to a leading expert in the field.
Your Experience or Concern:

Telemedicine Expert Consults FactMed newest feature allows patients to consult - via realtime videoconferencing - experts in AIRBORNE. This premium feature connects patients to experts, regardless of geography. FactMed experts charge reasonable rates that may be reimbursable by your insurance as a second-opinion.
We are currently accepting registration for AIRBORNE experts. If you are a healthcare provider experienced in prescribing AIRBORNE, please register here.
giCould not connect: